Introduction
Family-based linkage analysis has been highly successful in the study of Mendelian disorders. With few exceptions [Hugot et al., 2001; Musunuru et al., 2010; Ogura et al., 2001] , linkage analysis has been largely unsuccessful in contributing insights into the origin of complex traits or common diseases. In contrast, Genome-Wide Association Studies (GWAS) have been highly successful in identifying trait Supporting Information is available in the online issue at wileyonlinelibrary.com. * Correspondence to: Donald W. Bowden, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157, USA. E-mail:
dbowden@wakehealth.edu or disease associated common genetic variants. However, in most cases, GWAS have identified variants of relatively small effect sizes [Bodmer and Bonilla, 2008; Bowden, 2011] that contribute minimally to the variance in disease or quantitative traits. Investigators have speculated that low frequency variants, especially previously untested coding variants, will have larger effect sizes and contribute meaningfully to the variance in complex traits and common diseases [Kiezun et al., 2012] . Next-generation sequencing has facilitated the generation of extensive exome-sequencing data resources and made it possible to investigate the impact of coding variants.
In a prior exome sequencing analysis we have shown that a low frequency (1% minor allele frequency; MAF) coding . Here, we have performed an extensive analysis of family-based linkage and combined association analysis of 37 cardiometabolic phenotypes with data from exome chip analysis of 130 Hispanic and African-American families from the IRASFS to test the hypothesis that linkage analysis of coding variants can identify trait defining genetic variations.
Methods

Samples
The samples used in this study include both the Hispanic and African-American cohorts from the Insulin Resistance and Atherosclerosis Family Study (IRASFS). Ascertainment and examination of these cohorts have been previously described in detail [Henkin et al., 2003] . Briefly, subjects were ascertained on the basis of large family size in San Luis Valley, Colorado (Hispanics), San Antonio, Texas (Hispanics), and Los Angeles, California (African Americans). The Hispanic cohort consisted of 1,414 individuals from 90 families, while the African-American sample has 596 individuals from 42 families (Table 1) . These subjects were extensively phenotyped, including a frequently sampled intravenous glucose tolerance test (FSIGT), measures of blood lipids and inflammatory markers, anthropomorphic measures, and fat deposition measured by computed tomography (CT) scan (Supplementary Table S1 ). IRB approval was obtained at all clinical and analysis sites and all participants provided informed consent.
Exome Chip Genotyping and Quality Control
Genotyping was performed at the Wake Forest Center for Genomics and Personalized Medicine Research using the Illumina HumanExome BeadChip v1.0 (596 African Americans and 552 Hispanics) and v1.1 (862 Hispanics). Version 1.0 of the exome chip contained 247,870 variants, while version 1.1 contained 242,901. Over 92% of the variants were in protein coding regions. The chip also included 4761 single nucleotide polymorphisms (SNPs) previously associated with a diverse range of traits in prior GWAS (summary of exome chip design: http://genome.sph.umich.edu/ wiki/Exome_Chip_Design). Additional markers included coverage of the HLA region, ancestry informative markers, and SNPs for identity by descent determination. Relevant to the study reported here, the variants on the exome chips were chosen based on their appearance in more than one individual and more than one cohort and thus are likely to be observed in the general population.
Sample and autosomal SNP call rates for both the AfricanAmerican and Hispanic datasets were ࣙ99%, and SNPs with poor cluster separation (<0.35) were excluded. Mendelian errors were identified using PedCheck [O'Connell and Weeks, 1998 ] and resolved by removing conflicting genotypes. Hardy-Weinberg Equilibrium (HWE) was assessed for the variants on the exome chip using the program PLINK [Purcell et al., 2007] in only the unrelated samples (N = 39 and 229, African Americans and Hispanics, respectively), in order to reduce biases introduced by familial allele frequencies. In Hispanics, 7 variants had significant (P < 1 × 10 -5 ) deviation from HWE (minimum P-value = 7.2 × 10 -20 ). African-American variants were all in accordance with HWE (P > 1 × 10 -5 ).
Individual SNP Genotyping and Quality Control
Targeted genotyping of variants in APOE (chromosome 19), the neighboring gene APOC1, and APOB (chromosome 2) was also performed, including APOE variant rs429358, which in combination with rs7412 (contained on the exome chip) defined APOE isoforms ε2, ε3, and ε4. In addition to rs429358, SNPs were chosen from the NHLBI ESP GO (https://esp.gs.washington.edu/drupal/) [Tennessen et al., 2012] and 1000 Genomes [Abecasis et al., 2012] databases to more thoroughly cover the APOE/APOC1 and APOB regions. Coding variants seen in at least two AfricanAmerican samples from these resources were prioritized for genotyping, as well as variants predicted to impact splicing or causing frame-shift changes. Genotyping of 43 SNPs was carried out using the Sequenom Mass Array system (Sequenom; San Diego, CA). Blind duplicates (n = 22) were genotyped for quality control purposes and had a concordance rate of 99.6%. SNP and plate call rate thresholds were set at >90%. PedCheck [O'Connell and Weeks, 1998 ] was used to identify Mendelian inconsistencies, which were resolved by removal of conflicting genotypes. These SNPs were combined with the APOE-APOC1 and APOB variants contained on the exome chip for further analysis.
Statistical Analysis
Marker-specific identity-by-descent (IBD) probabilities were computed using the Monte Carlo method implemented in Sequential Oligogenic Linkage Analysis Routines (SOLAR) [Almasy and Blangero, 1998 ]. Trait variables were transformed to approximate normal distributions when necessary. Two-point linkage and measured genotype association analyses were also performed using the variance components method implemented in SOLAR, with age, gender, recruitment center (in the Hispanic cohorts), ancestry proportions (one principal component for African Americans, ADMIX-TURE [Alexander et al., 2009 ] variables 2-4 for Hispanics), and BMI as covariates. The measured genotype analysis, which accounts for the nonindependence of family members, involves incorporating each variant separately in a model as a measured covariate (the number of copies of the minor allele) evaluating genotype-specific differences in the trait means. The proportion of variance among the mean trait values for the genotypes to the total phenotypic variance was estimated as the contribution of the locus to variation in the trait.
Admixture in the Hispanic sample was estimated using an ADMIXTURE [Alexander et al., 2009] analysis from genomewide SNP data (N = 1,034 samples) pruned for LD from the Illumina OmniExpress as part of the Genetic and Epidemiologic Predictors of Glucose Homeostasis Measures in Hispanics (GUARDIAN) Consortium [data not shown]. All HapMap II populations were included (CEU, YRI, CHB, JPT) using a five population model. Admixture variables 2, 3, 4 represented variance within the IRASFS cohort while 1 and 5 did not vary within our sample. Admixture in the AfricanAmerican sample was estimated using principal components from 39 ancestry informative markers (AIMs) and including HapMap CEU and YRI samples for comparison . BMI was omitted as a covariate when assessing BMI for both association and linkage analyses, but was included for all other measures of adiposity and body composition.
Phasing of the APOE haplotypes was carried out manually based on the assumption that none of the individuals carried the extremely rare ε3r isoform, in which case the SNPs are completely predictive and phasing can be inferred.
Allelic interaction between all ApoB SNPs and the ApoE ε2 isoform (coded 0, 1, or 2 for number of copies of the ε2 isoform) was assessed using PLINK [Purcell et al., 2007] . This analysis was exploratory in nature and did not account for family structure.
Results
The goal of this study was to investigate the ability of familybased linkage analysis to identify coding variants linked to complex traits. Two-point linkage was chosen as the primary family-based linkage analysis tool. Multipoint linkage of variants in close proximity and consequent moderate to high linkage disequilibrium artificially inflates evidence of cosegregation. In the simplest scenario, a trait-defining variant will show evidence of linkage in the simple two-point analysis approach. The combination of two-point linkage with exome chip variants provides a comprehensive genome-wide assessment of coding and other SNPs observed across these American populations, i.e., are not private mutations. Specifically, we expected to observe evidence of linkage at a SNP that directly influences the cardiometabolic trait. Given the design of the exome chip was centered on coding variants, this SNP would likely have an annotation reflecting the role of the variant.
Two-point linkage analysis was performed using SOLAR on a total of 132 families with average family size of 14.2 (African American) and 15.7 (Hispanic) ( Table 1) . Table 1 also summarizes sample characteristics relevant to this analysis (demographic, biometric, and lipid levels). Overall the sample was representative of a population cross-section of adults in these populations.
African American Two-Point Linkage
A total of 92,157 (34%) variants in African Americans, were polymorphic and passed quality control metrics, including Mendelian error checking. Of these, 84% (77,526) are in coding regions, leaving 14,623 SNPs from intergenic regions ( Table 2 ). Assessment of HWE in this sample set indicated that no variants deviated from the expected (P < 1.0 × 10 -5 ). The two-point linkage analysis of the exome chip variants with 37 cardiometabolic phenotypes (Supplementary Table S1 ) yielded a total of nearly 3.5 million LOD scores computed in African Americans. To summarize the overall results (Table 2) , there were a total of 19,210 LOD scores greater than 1, 1,127 greater than 2, and 77 greater than 3, with a maximum identified LOD score of 4.91 with rs7412, a SNP at the APOE locus. In addition to linkage analysis, conventional SNP association analysis was performed accounting for family structure using SOLAR. A summary of LOD scores greater than 3.0 is shown in Supplementary Table S2 that lists both two-point LOD score and additive P-value for association. With the exception of rs7412 in the APOE locus (P-value = 4.4 × 10 -19 ), P-values for association in these linked variants are either nonsignificant (P > 0.05), or, at best, suggest nominal (P > 0.0001) association.
African Americans: Apolipoprotein B Levels and APOE
The maximum LOD score in African Americans was with the APOE SNP rs7412 (MAF = 0.12) and Apolipoprotein B (ApoB) levels. ApoB is the primary protein component of low-density lipoprotein particles. The rs7412 variant had a Pvalue for association with ApoB of 4.4 × 10 -19 (Table 3 ). The estimated effect corresponds to a reduction of 22 mg/dL in ApoB levels per minor allele of rs7412. The estimated proportion of variance of ApoB levels as attributable to rs7412 was 16.2%. This coding variant represents an arginine to cysteine amino acid change, which also is one of the two components defining the much-studied ApoE isoforms. In particular, this SNP is indicative of the ε2 isoform, which has often been implicated as protective of cardiovascular changes, as well as Alzheimer's disease.
African Americans: Additional APOE, APOC1, and APOB Genotyping
Additional APOE and APOC1 variants (absent from the exome chip) including rs429358, the other SNP determinant of the canonical ApoE isoforms, were also genotyped and data analyzed as summarized in Table 3 . No other genotyped SNP showed stronger evidence of linkage or association than rs7412, including rs429538 (MAF = 0.21). There was very little linkage disequilibrium across the APOE region, with only one variant having an r 2 value of at least 0.40 with one of the isoform-determining SNPs (rs7412 and rs445925; Supplementary Fig. S1 ). Combining rs7412 and rs429358 into APOE haplotypes resulted in LOD = 4.40 and P-value for association of 6.6 × 10 -13 accounting for an estimated 23.6% of the variance in ApoB (Table 3 ). Figure 1 summarizes the means of each haplogenotype for ApoE isoforms. Haplogenotypic means were 51.4 mg/dL for homozygous ε2, 89.2 mg/dL for homozygous ε3, and 102.2 mg/dL for homozygous ε4. The figure shows the clear trend for increasing numbers of ε2 alleles and decreasing ApoB. The statistically significant linkage and association (LOD>3; P-value <5 × 10 -7 ) results for the APOE-APOC1 locus were driven largely by the APOE haplotype based on analyses conditioning on APOE (Supplementary Table S3 ). In addition, since APOE and ApoB proteins are both components of lipoprotein particles, allelic interaction between APOE ε2 isoform and APOB variants were assessed for their contribution to the evidence of linkage and association. Although some APOB variants are associated with ApoB levels, (Supplementary Table S4 ) they explain little variance in ApoB levels and there was limited evidence of APOB × APOE interaction (Supplementary  Table S5 ),
Twopoint Linkage Analysis in Hispanic Americans
The Hispanic set resulted in 81,559 (31%) polymorphic SNPs passing quality control (Table 2) . Coding SNPs represented 82% of the polymorphic SNPs, with 14,639 additional intergenic SNPs remaining for analysis. In this sample set seven SNPs deviated from expected HWE Equilibrium (P < 1.0 × 10 -5 ). The linkage results for the Hispanic sample included 18,840 LOD scores greater than 1, 1,216 greater than 2 and 104 greater than 3 (Table 2) . A previously identified linkage peak on chromosome 3 for adiponectin was overrepresented in the strong linkage results, which are presented in Supplementary Table S6 , alongside corresponding P-values for association for those variants. Excluding the chromosome 3 locus, the most biologically interesting result was evidence of linkage with HDL levels on chromosome 16 with a variant in the CETP gene (rs5882, LOD = 4.29). The CETP protein is known to facilitate exchange of cholesterol esters for triglycerides between HDL and triglyceride-rich lipoprotein remnants.
Hispanic Americans: CETP
In addition to rs5882 there were 11 additional variants in and near CETP on the exome beadchip. The result of linkage and association with these variants are summarized in Table 4 . Only the initial exome chip variant, rs5882, showed strong evidence of linkage with the next highest LOD score being less than 2. The CETP locus has extensive evidence of association with HDL with the strongest association (P-value = 4.6 × 10 -12 ) seen with a promoter SNP rs247616. Multiple other SNPs were also strongly associated, with a range of P-values of less than 10 -6 . In contrast to the APOE results, the most strongly linked SNP rs5882 was more nominally associated with HDL levels (P = 0.00049). The most significantly associated SNP in this gene region (rs247616) accounted for 4.5% of the variance in HDL levels in this population while the linked SNP rs5882 explained an estimated 1.2% (Table 4) .
To gain a better picture of the complex pattern of linkage and association with HDL in the CETP locus analyses conditioning on rs5882 (the strongest linkage) and rs247616 (the most associated) were performed (Table 5) . Conditioning on rs5882 reduced, but did not eliminate evidence of linkage in SNPs with prior nominal evidence of linkage (e.g., rs9939224) suggesting rs5882 alone does not explain the linkage evidence. Conditional analysis of the association data, however, suggested that rs247616 (or a SNP in high LD) largely accounted for evidence of association with P-values substantially reduced and only modest evidence of residual variance. It is notable that rs247616 is part of an LD block ( Supplementary Fig. S2 ). Although there was substantial LD across the promoter region, there was less between the coding regions of the gene (in particular, the linked SNP rs5882) and the promoter and upstream areas of significant association (P-value <6 × 10 -7 ). The genotypic means of rs247616 and rs5882 follow an additive pattern and are presented in Supplementary Table S7 . 
Discussion
In this study, we have performed analysis of family-based linkage and association analysis of exome chip data from 130 Hispanic-American and African-American families from the IRASFS with 37 cardiometabolic phenotypes. The goal of the study was to test the hypothesis that linkage analysis of coding variants can identify trait defining genetic variations. Based on the exome chip design, this analysis tested primarily coding variants that were distributed in the general population. It is noteworthy that it has been argued previously that linkage is only effective when the variant or locus of interest is contributing a large proportion of the variance of the disease or trait [Risch and Merikangas, 1996; Risch, 2000] . The results here, especially the two highlighted linkages with APOE and CETP are consistent with this model. APOE and CETP had the strongest evidence of linkage. SNPs at these loci were strongly associated with the linked traits (P-values for the top associated SNPs of 4.4 × 10 -19 for the APOE locus and 4.6 × 10 -12 at the CETP locus; Tables 3 and 4). Association P-values for other SNPs on the chip with LODs greater than 3 were more nominal (P-value >0.0001). Given the large number of tests, we suspect that many of the other LOD scores greater than 3 may not represent true linkages. The two most prominent linkage results were highly consistent with prior genetic studies [Anuurad et al., 2009; Chasman et al., 2008; Edmondson et al., 2011; Lu et al., 2008; Ozturk et al., 2010] and were the focus of more detailed analysis.
The APOE SNP rs7412 in African Americans provided the most striking linkage and association results with the ApoB phenotype. The association with ApoB appeared to be driven by the APOE locus rather than the influence of the ApoB coding locus (APOB) (Supplementary Tables S4 and S5) . APOE has been an intensively studied genetic locus from multiple perspectives including a well-documented association with lipid levels such as LDL cholesterol [Anand et al., 2009; Chasman et al., 2006 Chasman et al., , 2008 Chasman et al., , 2012 Coram et al., 2013; Klos et al., 2008; Teslovich et al., 2010; Waterworth et al., 2010] . However, association with ApoB levels has been noted only in a small number of studies with SNPs in the region, and the isoforms have only had moderate study in this context [Chasman et al., 2008 [Chasman et al., , 2012 Ozturk et al., 2010; Surakka et al., 2012] . Particularly, Anuurad et al. showed a marked difference in ApoB levels in African Americans, but not Caucasians by ApoE isoform in 232 African Americans and 326 Caucasians; P < 0.05 [Anuurad et al., 2009] . In addition to ApoB we have assessed the linkage and association with other lipid traits (Supplementary Table S8) , and found association with LDL (P = 7.5 × 10 -10 ), total cholesterol (P = 1.4 × 10 -6 ) and modest evidence of linkage and no compelling association with HDL and triglycerides.
In this African-American sample, the APOE isoforms explain over 23% of the variance in ApoB levels ( Table 3) that contrasts with an estimated 13% of the variance for LDL (Supplementary Table S8 ). APOE was not linked to ApoB in the larger Hispanic cohort (rs7412; LOD = 0.15) but was associated (rs7412; P = 5.7E-06; Supplementary Table S9) . rs7412 and APOE isoforms explained a comparatively modest amount of the variance of ApoB and LDL (rs7412, 3.3% and 3.2% respectively; APOE, 2.8% and 2.8%, respectively). Prior estimates of APOE contributions to LDL variance range from 3.3% to 4.1% in non-African derived populations (24-28).
The association of the CETP locus with HDL levels, seen here in the Hispanic sample, is well documented. CETP facilitates exchange of cholesterol esters for triglycerides between HDL and triglyceride-rich lipoprotein remnants. CETP has previously been associated with HDL levels in numerous studies, albeit with different index SNPs [Chasman et al., 2008; Edmondson et al., 2011; Lu et al., 2008; Papp et al., 2012; Reddy et al., 2012; Teslovich et al., 2010; Waterworth et al., 2010; Wu et al., 2013] in which collections of various SNPs at the CETP locus in various ethnic groups were estimated to account for approximately 3-4% of the variance in HDL. Contribution to variance however has not been analyzed previously in a Hispanic sample, though our proportion of variance attributable to the CETP locus (ß5.5%) is comparable to those seen in other ethnic groups.
Results of analysis with the CETP locus in African Americans were qualitatively different from the Hispanics (Supplementary Table S10 ). In African Americans, only 4 of the 15 polymorphic variants in this region were nominally associated (P-values ranging from 0.001 to 0.05). The strongest association (P-value = 0.0010) here was with an intronic CETP variant, rs7499892, which explained 2.3% of the HDL variance in this African-American cohort with no evidence of linkage to HDL. This variant was monomorphic in the Hispanic sample, and was therefore not available for linkage and association testing.
We focused here on two previously well-documented loci, APOE and CETP, to assess performance of family-based linkage in an exome-wide analysis. There were, however, 68 other LOD scores greater than 1 and 11 LOD scores greater than 2 at SNPs that also have association P-values down to 1 × 10 -5 . These loci bear further evaluation. A number of the nominal linkages (e.g., LOD > 3) were also nominally associated (0.0001 < P < 0.05; Supplementary Tables S2 and S4 ). Testing of whether these more nominal linkages represent true effects will require additional data from other family studies. In addition, this study was based on exome chip genotyping and therefore does not touch on the possibility that private mutations, i.e., coding variants in a single lineage, may contribute to overall variance in traits. This will be possible to test when the planned exome sequencing of the IRASFS Hispanic families is completed. Another path of examination in these family-based cohorts would be the examination of single families for rare variants with high impact on a trait. While possibly productive, the number of computed LOD scores for 132 families with >20,000 SNPs suggests it will be challenging to identify real linkage in a background of a potentially very high proportion of false positives.
The results of this study emphasize the utility of exome chips and linkage analysis in detecting relevant traitassociated variants. It is also of note that the cohorts examined were small (n = 600-1400) relative to extremely large GWAS. Despite this limitation, the family-based design of these cohorts allowed for the use of linkage analysis in conjunction with association, which was successful in identifying highimpact variants. The APOE and CETP results add to the prior identification of a high impact variant in the ADIPOQ locus . Thus, linkage and association were observed in multiple scenarios: an uncommon variant (1% MAF, ADIPOQ), a relatively common variant (12% MAF, APOE), and a combination of common variants (CETP). The characteristic that these have in common is a substantial contribution to the variance in the trait. In summary, linkage in families remains a powerful tool for discovery in human genetics, especially when combined with conventional association analysis.
